Latest Staphylococcus aureus Stories
UV disinfection device is game-changer for patients and hospital leaders alike MEMPHIS, Tenn., Aug.
BILTHOVEN, the Netherlands, July 30, 2014 /PRNewswire/ -- Dutch market research panel 'hettestpanel.nl' tested Gladskin Skin Irritation on a large group of men and women
PITTSBURGH, July 22, 2014 /PRNewswire/ -- Hussey Copper, a leader in copper manufacturing and maker of MD-Cu(29) antimicrobial copper announces Pullman Regional Hospital's conversion of more
Transparency Market Research published a new report "Global Hospital Infection Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast- 2018" to its report store.
To Effectively Compete with Current Anti-MRSA Therapies, Emerging Agents Will Need to be Amenable to Outpatient Use, According to Findings from Decision Resources Group BURLINGTON, Mass., July
SAN DIEGO, July 1, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Deal marks company's biggest deployment of groundbreaking healthcare worker safety enhancing uniforms ORLANDO, Fla., June 24, 2014 /PRNewswire/ --
FAIRFIELD, N.J., June 12, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that its licensor, Ferrer, has initiated the second Phase III clinical study for Ozenoxacin,
GLASGOW, Scotland, June 2, 2014 /PRNewswire/ -- MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer,
Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...